Healnet Description
Rare diseases often lack comprehensive research, resulting in insufficient knowledge about essential elements for an effective drug discovery initiative. Our innovative AI platform, Healnet, addresses these issues by scrutinizing vast amounts of drug and disease data to uncover new connections that may lead to potential treatments. Utilizing cutting-edge technologies throughout the discovery and development process allows us to operate multiple phases simultaneously and on a large scale. The conventional approach of focusing on a single disease, target, and drug is overly simplistic, yet it remains the standard for most pharmaceutical companies. The future of drug discovery is driven by AI, characterized by parallel processes and an absence of rigid hypotheses, fundamentally integrating the three core paradigms of drug discovery into a cohesive strategy. This new paradigm not only enhances efficiency but also fosters creativity in developing solutions for complex health challenges.
Healnet Alternatives
FrameworkLTC's fully integrated and scalable platform automates all manual tasks, allowing LTC pharmacies to focus on what is most important: improving patient lives. Automation replaces manual tasks and allows you to expand your business while maximising margins. Delivering services that meet the needs of each facility will strengthen your partner relationships. Our facility-centric software allows you to provide concierge-level service, catering to every patient, wing, and facility. Allow facilities to print bills, check order statuses, and process returns according to your pre-defined rules. Your facilities will appreciate your reports. Automate refill and reorder prescriptions so they don't get lost on the production floor.
Learn more
JDisc Discovery is a powerful IT asset management and network discovery tool, designed to provide organizations with clear, real-time insights into their entire IT environment. By automatically scanning the network, it identifies and catalogs devices, from physical servers and workstations to virtual machines and network appliances, giving users a detailed inventory of their assets. The tool captures essential data such as hardware specifications, installed software, system configurations, and interdependencies among devices.
A key advantage of JDisc Discovery is its agentless architecture. Rather than requiring installation on each device, it uses multiple protocols (like SNMP, SSH, WMI) to gather information, ensuring quick deployment and compatibility across various operating systems, including Windows, Linux, and Unix. This makes it ideal for diverse and dynamic IT ecosystems, enabling efficient and non-intrusive data collection.
Learn more
Recursion
Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.
Learn more
Atomwise
Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.
Learn more
Integrations
No Integrations at this time
Company Details
Company:
Healx
Year Founded:
2014
Headquarters:
United Kingdom
Website:
healx.io/technology/
Media
Recommended Products
MongoDB Atlas runs apps anywhere
MongoDB Atlas gives you the freedom to build and run modern applications anywhere—across AWS, Azure, and Google Cloud. With global availability in over 115 regions, Atlas lets you deploy close to your users, meet compliance needs, and scale with confidence across any geography.
Product Details
Platforms
Web-Based
Customer Support
Online Support
Healnet Features and Options
Healnet User Reviews
Write a Review- Previous
- Next
